Ith focus around the evaluation of their impact on CLL immune escape. Altogether, this study will give insight in to the distinct immune and stromal cells involved in CLL improvement, with emphasis on their involvement in tumour-derived compact Ev-mediated tumour immune escape. Funding: This project is funded by the Fonds National de la Recherche (FNR) INTER/DFG/16/11509946/EVRNA/Moussay. Sandrine Pierson and J e Paggetti are supported by the FNR INTER/DFG/16/11509946/EV-RNA/ Moussay. Ernesto Gargiulo is supported by the grant FNR Luxembourg PRIDE15/10675146/CANBIO.PT06.Interaction by means of exosome miRNAs in between myelodysplatic cell and typical Treg Tatsuki Shibuta, Yukichi Takada and Tsukuru Umemura International University of Wellness and Welfare, Okawa City, Japanregulatory T cells (Treg) that have been sorted from normal peripheral blood. The Exosomes have been detected in cytosol of Treg by fluorescent microscopy. Microarray evaluation of miRNAs in Treg intaking MDS-exosomes showed that important increases of 9 miRNAs in MDS-exosomes. The conditioned medium of MDSexosomes treated Treg culture reduced the population of activated CD4 cells (CD38 optimistic cells was 39 ; handle 68). Summary/Conclusion: Our information recommended that exosomes from MDS cells affected the function of regulatory T cells by way of miRNA transfer. MDS exosomes could effect on immune cells to avoid the exclusion from cancer-immune system, and may be a target for the new therapies or diagnostic techniques. Funding: This operate was supported in part by a grant from the Japan Society for the Promotion of Science (JSPS KAKENHI Grant Number: JP17K09020 and 17H07059).PT06.Mechanism of antitumor immunity activation by `artificial PPARĪ“ list neoantigen’-presenting exosomes Yoshiyuki Koyamaa, Tomoko Itoa, Masazumi Eriguchia, Aya Hasegawab, Wakana Ouchic, Toshio Inabab and Kikuya SugiurabaIntroduction: Myelodysplastic Syndrome (MDS) is actually a clonalhematopoietic disease and develops leukaemia in some instances. As a result, MDS is a malignant hematopoietic illness and its prevalence ratio is escalating in Japan. Hematopoietic microenvironment like bone marrow niche is really a critical aspect for sustaining leukaemic stem cells. To know mechanisms of interactions involving leukaemic stem cells and microenvironment is essential for the therapy of hematopoietic malignancies. In this study, to create the new therapies and diagnostic strategies for MDS, we focused around the impact of exosomes released from MDS cells on peripheral T lymphocytes. Strategies: MDS cell line (MDS-L) was kindly provided by Kasawaki Healthcare University and normal peripheral blood mononuclear cells were obtained from healthful volunteer donors. Exosomes from MDS cells were purified by using miRCURY Exosome Cell/Urine/CSF Kit and labelled by PKH67. Extracted miRNAs were analysed by microarray system (Genopal, Mitsubishi Chemical, Japan). Cell surface antigens had been analysed by FACS Aria II and fluorescence conjugated antibodies. Results: miRNA-microarray analysis showed that nine miRNAs have been abundant in exosomes from MDS cells and have been not detected in MDS cells. Exosomes labelled with PKH67 dye have been added to liquid culture STAT6 review ofJapan Anti-tuberculosis Association, Shin-Yamanote Hospital, Tokyo, Japan; Osaka Prefecture University, Osaka, Japan; cOsaka Prefecture University, Tokyo, JapanbIntroduction: Tumour-derived exosomes are identified to have identical antigens because the parent tumour cells, and have been anticipated as cancer vaccines. Nonetheless, treatment with these exosomes normally failed to elicit.